Clinical Trial Update: Tolerance Study of Allogeneic of Adipose Tissue Derived Mesenchymal Stroma/Stem Cells (AdMSC) Transplantation in Patients With Critical Limb Ischemia. [Phase 1]

View source ↗

Summary

Phase 1 tolerance study evaluating allogeneic adipose tissue–derived mesenchymal stem/stromal cells (AdMSC) transplantation for critical limb ischemia; currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• Allogeneic adipose tissue-derived mesenchymal stromal/stem cells (AdMSC) (adipose tissue-derived mesenchymal stromal/stem cells)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Critical Limb Ischemia | Phase 1 | Status: NOT_YET_RECRUITING